Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Free Radic Biol Med ; 46(5): 616-23, 2009 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-19100829

RESUMO

Heme-mediated oxidative modification of low-density lipoprotein (LDL) plays a crucial role in early atherogenesis. It has been shown that hydrogen sulfide (H(2)S) produced by vascular smooth muscle cells is present in plasma at a concentration of about 50 micromol/L. H(2)S is a strong reductant which can react with reactive oxygen species like superoxide anion and hydrogen peroxide. The current study investigated the effect of H(2)S on hemin-mediated oxidation of LDL and oxidized LDL (oxLDL)-induced endothelial reactions. H(2)S dose dependently delayed the accumulation of lipid peroxidation products-conjugated dienes, lipid hydroperoxides (LOOH), and thiobarbituric acid reactive substances-during hemin-mediated oxidation. Moreover, H(2)S decreased the LOOH content of both oxidized LDL and lipid extracts derived from soft atherosclerotic plaque, which was accompanied by reduced cytotoxicity. OxLDL-mediated induction of the oxidative stress responsive gene, heme oxygenase-1, was also abolished by H(2)S. Finally we have shown that H(2)S can directly protect endothelium against hydrogen peroxide and oxLDL-mediated endothelial cytotoxicity. These results demonstrate novel functions of H(2)S in preventing hemin-mediated oxidative modification of LDL, and consequent deleterious effects, suggesting a possible antiatherogenic action of H(2)S.


Assuntos
Aterosclerose/enzimologia , Células Endoteliais/metabolismo , Hemina/metabolismo , Sulfeto de Hidrogênio/farmacologia , Lipoproteínas LDL/fisiologia , Aterosclerose/patologia , Aterosclerose/prevenção & controle , Morte Celular/efeitos dos fármacos , Morte Celular/fisiologia , Linhagem Celular , Citoproteção , Células Endoteliais/patologia , Humanos , Metabolismo dos Lipídeos/efeitos dos fármacos , Peróxidos Lipídicos/sangue , Lipoproteínas LDL/sangue , Oxirredução , Estresse Oxidativo/fisiologia , Veias Umbilicais/patologia
2.
J Nutr Biochem ; 19(5): 320-7, 2008 May.
Artigo em Inglês | MEDLINE | ID: mdl-17683924

RESUMO

Tocopherol vitamers [e.g., alpha-, gamma- and delta-tocopherol (alpha-TOC, gamma-TOC and delta-TOC, respectively)] and their water-soluble 2,2'-carboxyethyl hydroxychroman metabolites (e.g., alpha-, gamma- and delta-CEHC) all possess antioxidant properties. As a consequence, and similarly to other natural antioxidants, vitamin E compounds may be useful in preventing inflammatory and oxidative-stress-mediated diseases. In this study, we investigated the concentration-dependent effect of tocopherols and water-soluble metabolites on a key event in oxidative stress, for example, the oxidative burst in neutrophils. It was found that not only alpha-TOC but also gamma-TOC and delta-TOC as well as alpha-, gamma- and delta-CEHC at physiological concentrations inhibit superoxide anion (O2(*-)) production in phorbol-ester-stimulated neutrophils. This effect was mediated by the inhibition of the translocation and activation of protein kinase C (PKC) enzyme, which is the key event in the phorbol-ester signaling. Importantly, CEHCs were stronger inhibitors of PKC as compared with the vitamer precursors, and the gamma forms of both tocopherol and CEHC showed the highest inhibitory activities. Tocopherols, but not CEHCs, directly inhibit the fully activated nicotine-adenine-dinucleotide phosphate (NADPH) oxidase. However, none of the test compounds was able to directly scavenge O2(*-) when tested in a cell-free system. In conclusion, vitamin E compounds can control the neutrophil oxidative burst through the negative modulation of PKC-related signaling and NADPH oxidase activity. As an original finding, we observed that CEHC metabolites might contribute to regulate PKC activity in these cells. These results may have important implications in the anti-inflammatory and antioxidant role of vitamin E compounds.


Assuntos
Antioxidantes/farmacologia , Cromanos/farmacologia , Neutrófilos/efeitos dos fármacos , Acetato de Tetradecanoilforbol/toxicidade , Tocoferóis/farmacologia , Antioxidantes/química , Antioxidantes/farmacocinética , Carcinógenos/toxicidade , Células Cultivadas , Cromanos/química , Citocromos c/metabolismo , Relação Dose-Resposta a Droga , Humanos , NADPH Oxidases/metabolismo , Neutrófilos/enzimologia , Neutrófilos/metabolismo , Estresse Oxidativo/efeitos dos fármacos , Proteína Quinase C/antagonistas & inibidores , Proteína Quinase C/metabolismo , Explosão Respiratória/efeitos dos fármacos , Superóxidos/metabolismo , Fatores de Tempo , Tocoferóis/química , Tocoferóis/farmacocinética , Ácido Úrico/metabolismo , Xantina Oxidase/antagonistas & inibidores , Xantina Oxidase/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...